TY  - JOUR
AU  - González Del Alba, A
AU  - De Velasco, G
AU  - Lainez, N
AU  - Maroto, P
AU  - Morales-Barrera, R
AU  - Muñoz-Langa, J
AU  - Pérez-Valderrama, B
AU  - Basterretxea, L
AU  - Caballero, C
AU  - Vazquez, S
PY  - 2018
DO  - 10.1007/s12094-018-02001-x
UR  - http://hdl.handle.net/10668/13329
T2  - Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
AB  - The goal of this article is to provide recommendations about the management of muscle-invasive (MIBC) and metastatic bladder cancer. New molecular subtypes of MIBC are associated with specific clinical-pathological characteristics. Radical cystectomy...
LA  - en
KW  - Bladder cancer
KW  - Chemotherapy
KW  - Cystectomy
KW  - Immune checkpoint inhibitors
KW  - Clinical Trials as Topic
KW  - Combined Modality Therapy
KW  - Disease Management
KW  - Humans
KW  - Muscle Neoplasms
KW  - Neoplasm Invasiveness
KW  - Practice Guidelines as Topic
KW  - Prognosis
KW  - Societies, Medical
KW  - Urinary Bladder Neoplasms
TI  - SEOM clinical guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2018).
TY  - research article
VL  - 21
ER  -